Clinical Immunology Gastric Cancer Increase the Percentage of Intermediate (CD14++CD16+) and Nonclassical (CD14+CD16+) Monocytes

Central-European Journal of Immunology - Poland
doi 10.5114/ceji.2012.32725

Related search